Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

857
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
857
Tumor Progression02:07

Tumor Progression

6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Steatotic Liver Disease at Primary Biliary Cholangitis Diagnosis: Association With Ursodeoxycholic Acid Response and Outcomes.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Preoperative endoscopic tattooing and its effect on lymph node recovery in pT1 colorectal cancer.

Gastroenterologia y hepatologia·2026
Same author

Erratum to 'BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update' [J Hepatol (2026) 631-654].

Journal of hepatology·2026
Same author

Accuracy and variability of locoregional staging in T1 rectal cancer: nationwide multicentre cohort study.

BJS open·2026
Same author

Correction: Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages.

Frontiers in immunology·2026
Same author

Copy-Neutral Loss of Heterozygosity in Myelofibrosis: Parallel Evaluation with Optical Genome Mapping and Single-Nucleotide Polymorphism Arrays.

The Journal of molecular diagnostics : JMD·2026

Related Experiment Video

Updated: Apr 23, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

869

Prognosis prediction and staging.

Alejandro Forner1, Alvaro Díaz-González2, Alexandre Liccioni2

  • 1Liver Unit, Barcelona Clinic Liver Cancer (BCLC) Group, Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Spain.

Best Practice & Research. Clinical Gastroenterology
|September 28, 2014
PubMed
Summary

The Barcelona Clinic Liver Cancer (BCLC) staging system is crucial for assessing hepatocellular carcinoma (HCC) prognosis and guiding treatment. It categorizes patients to direct them to the most effective care, from curative options to supportive measures.

Keywords:
BCLCHepatocellular carcinomaPrognosisStaging system

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Related Experiment Videos

Last Updated: Apr 23, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

869
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Area of Science:

  • Hepatology
  • Oncology
  • Clinical Management

Background:

  • Hepatocellular carcinoma (HCC) management requires accurate staging and prognosis assessment.
  • HCC is often linked to chronic liver disease, necessitating consideration of tumor burden, liver function, and symptoms.
  • Effective staging systems must correlate with treatment indications based on scientific evidence.

Purpose of the Study:

  • To highlight the importance of the Barcelona Clinic Liver Cancer (BCLC) staging system.
  • To explain how the BCLC system guides treatment decisions for hepatocellular carcinoma patients.
  • To underscore the BCLC system's role in linking prognosis with therapeutic strategies.

Main Methods:

  • The study reviews the Barcelona Clinic Liver Cancer (BCLC) staging system.
  • It outlines the classification of HCC patients into distinct stages: very early/early, intermediate, advanced, and end-stage.
  • Treatment recommendations are aligned with each BCLC stage.

Main Results:

  • The BCLC staging system categorizes HCC patients into four main groups.
  • Treatment strategies range from potentially curative options (resection, transplantation, ablation) for very early/early stages.
  • Intermediate stages are treated with chemoembolization, advanced stages with sorafenib, and end-stage with best supportive care.

Conclusions:

  • The BCLC staging system is the current standard for staging and guiding treatment in hepatocellular carcinoma.
  • It effectively links patient prognosis with appropriate therapeutic interventions.
  • Accurate staging using the BCLC system is essential for optimal HCC patient management.